cases of a rare and extreme type of blood embolisms in individuals after getting the J&J vaccine. Press Release/ Public Declaration 04/12/2021 As FDA commemorates National Minority Health Month, we're working to resolve issues about vaccines amongst diverse neighborhoods, and to secure and promote the health of diverse populations by focusing our efforts on techniques that address health disparities.
Food and Drug Administration revealed two modifications regarding the number of dosages per vial offered for the Moderna COVID-19 Vaccine. Press Release/ Public Statement 03/26/2021 The FDA issues an emergency situation use permission (EUA) to a business for the SARS-Co, V-2 NGS Assay and supplies a customer upgrade on common concerns about COVID-19 vaccines.
Consumer Details 03/17/2021 FDA leadership will take part in the House Subcommittee on Oversight and Examinations of the Committee on Energy and Commerce hearing entitled, "Blazing a trail Forward: Biden Administration Actions to Increase COVID-19 Vaccinations." View livestream and written testimony Occasion 03/05/2021 FDA's Office of Minority Health and Health Equity talks about the company's efforts to stop deceitful products from reaching our markets, particularly those claiming to prevent, treat, or cure COVID-19.
Blog site Post 03/02/2021 The FDA issues Voices on protecting consumers versus COVID-19 vaccine frauds and problems a warning letter to a company selling unapproved products with deceitful COVID-19 claims. News Release/ Public Declaration 02/27/2021 Today, the U.S. Food and Drug Administration provided an emergency situation usage authorization (EUA) for the 3rd vaccine for the avoidance of coronavirus disease 2019 (COVID-19) triggered by serious intense respiratory syndrome coronavirus 2 (SARS-Co, V-2).
COVID-19 Vaccine, the FDA has actually informed the sponsor that it will quickly pursue finalization and issuance of an emergency usage permission. News Release/ Public Statement 02/26/2021 Today, the FDA included brand-new devices to the gadget discontinuance list, consisting of sterilization items and oxygen conservers. COVID-19 Update 02/26/2021 The Vaccines and Associated Biological Products Advisory Committee will fulfill in open session to go over Emergency situation Use Authorization (EUA) of the Janssen Biotech Inc.